[FURL=https://www.industryarc.com/Research/Ioversol-Market-Research-501632?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]Ioversol Market[/FURL] size is expected to be valued at $857 million by the end of the year 2026 and is set to grow at a CAGR of 7.2% during the forecast period from 2021-2026. Ioversol is an organoiodine compound that is found in everyday iodine salt composition and is mandated by the government for health reasons. Ioversol are sterile contrast dye used in diagnostic radiocontrast agent administered for patients during CT scans and X-ray procedures for increasing the image contrast.Key Takeaways
North American market held the largest share in the ioversol market owing to the growing healthcare infrastructure and increase in demand from hospitals for image testing on cardiovascular patients.
The increase in the incidence of number of accidents across the globe is giving rise to the need for scanning and X-ray procedures which is further driving the Ioversol market.
Increasing diseases and health conditions in patients across the globe is driving the ioversol market.
Amid the Covid-19 pandemic, the ioversol market witnessed a considerable amount of growth owing to the increase in the diseases and health conditions during the pandemic.
Download Sample Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=501632[/FURL]
Ioversol Market Segment Analysis – By Geography
North American region held the largest share of 42% in the ioversol market in the year 2020. The increase in the growth of the medical and healthcare system in the North America region is majorly driving the ioversol market. According to National Health Expenditure Accounts (NHEA), the US healthcare spending grew by 4.6% in the year 2019 reaching US11,583 per person in the US. According to Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women and people of most racial and ethnic groups in United States. According to Heart disease and stroke statistics—2020 update: a report from the American Heart Association, about 655,000 Americans die from heart disease every year, that is 1 in every 4 deaths.
Ioversol Market Drivers
Increasing case of heart diseases
Increasing brain-related health conditions
oversol Market Industry Outlook
Investments, acquisitions and mergers, production expansion, collaborations, facility expansion and partnerships are some of the key strategies adopted by players in the Ioversol Market. Major players in the Ioversol Market are Liebel-Flarsheim Company LLC, Jiangsu Hengrui Medicine Co, Ultraject, Stellence Pharmscience Pvt. Ltd, China Resources Pharmaceutical (Shanghai) Co, A.S. Joshi & Company, Mallinckrodt Pharmaceuticals, Novalek Pharmaceuticals Pvt. Ltd, HB Ocean and Guerbet among others.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.